Coasting acts through downregulation of VEGF gene expression and protein secretion

被引:38
作者
García-Velasco, JA
Zúñiga, A
Pacheco, A
Gómez, R
Simón, C
Remohí, J
Pellicer, A
机构
[1] Rey Juan Carlos Univ, IVI Madrid, Madrid 28035, Spain
[2] IVI Fdn, Valencia, Spain
关键词
coasting; ovarian hyperstimulation syndrome; VEGF;
D O I
10.1093/humrep/deh298
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: This study was conducted to investigate the mechanisms by which coasting may be effective in decreasing the incidence of ovarian hyperstimulation syndrome (OHSS). METHODS: A total of 160 women (patients and oocyte donors) undergoing coasting and 116 controls were included in the study. Serum, follicular fluid and granulosa cells were collected on the day of oocyte retrieval. Vascular endothelial growth factor (VEGF) concentrations were determined using an enzyme-linked immunosorbent assay (ELISA). Real-time PCR was performed to evaluate VEGF gene expression in granulosa cells. Cell death was studied by flow cytometry using annexin V-fluorescein isothiocyanate (FITC) and counterstaining by propidium iodide, and double staining with CD45 monoclonal antibody was performed to distinguish the contamination of apoptotic leukocytes. RESULTS: Follicular cells aspirated from coasted patients showed a ratio in favour of apoptosis, especially in smaller follicles (48 versus 26%, P < 0.05). Follicular fluid determinations confirmed that coasting reduces VEGF protein secretion (1413 versus 3538 pg/ml, P < 0.001) and gene expression (2-fold decrease) in granulosa cells. Follicular fluid VEGF protein levels positively correlated with follicular size (r = 0.594, P = 0.001) and estradiol production (r = 0.558, P = 0.038). Women who underwent coasting showed a comparable IVF cycle outcome; however, a higher cancellation rate was found in cycles that were coasted. CONCLUSIONS: Coasting affects all follicles through apoptosis, especially immature follicles, without affecting oocyte/endometrial quality. The significant decrease found in VEGF expression and secretion explains why coasting is clinically effective in reducing the incidence and severity of OHSS.
引用
收藏
页码:1530 / 1538
页数:9
相关论文
共 31 条
[1]   Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries [J].
Agrawal, R ;
Jacobs, H ;
Payne, N ;
Conway, G .
FERTILITY AND STERILITY, 2002, 78 (06) :1164-1169
[2]   Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients [J].
Al-Shawaf, T ;
Zosmer, A ;
Hussain, S ;
Tozer, A ;
Panay, N ;
Wilson, C ;
Lower, AM ;
Grudzinskas, JG .
HUMAN REPRODUCTION, 2001, 16 (01) :24-30
[3]   Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome [J].
Benadiva, CA ;
Davis, O ;
Kligman, I ;
Moomjy, M ;
Liu, HC ;
Rosenwaks, Z .
FERTILITY AND STERILITY, 1997, 67 (04) :724-727
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   Follicle-stimulating hormone and luteinizing hormone chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles [J].
Christenson, LK ;
Stouffer, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2135-2142
[6]   Hormonal regulation of apoptosis in early antral follicles: Follicle-stimulating hormone as a major survival factor [J].
Chun, SY ;
Eisenhauer, KM ;
Minami, S ;
Billig, H ;
Perlas, E ;
Hsueh, AJW .
ENDOCRINOLOGY, 1996, 137 (04) :1447-1456
[7]   Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577
[8]   Preventive attitude of physicians to avoid OHSS in IVF patients [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION, 2001, 16 (12) :2491-2495
[9]   Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization [J].
Enskog, A ;
Henriksson, M ;
Unander, M ;
Nilsson, L ;
Brännström, M .
FERTILITY AND STERILITY, 1999, 71 (05) :808-814
[10]   Manipulation of human ovarian function: Physiological concepts and clinical consequences [J].
Fauser, BCJM ;
VanHeusden, AM .
ENDOCRINE REVIEWS, 1997, 18 (01) :71-106